Micron successfully executed a large, 4-year publication programme, beginning in 2012, for the anti-infective portfolio of a major pharmaceutical company. The client required data from four randomised clinical trials, a registry study and several pharmacokinetics studies to be published in highly respected peer-reviewed journals alongside posters to be presented at major international conferences. New data were generated every few months and one compound had been filed for marketing authorisation via a novel fast-track approval pathway, meaning continual revision of the publication plan was necessary to ensure up-to-date content was disseminated.

Micron assigned a designated writer to produce and manage the progress of each manuscript from initial outline to submission within tight, defined timeframes. All authors, who were either investigators on the studies or employees of the client company, were consulted and provided feedback at every draft. Our writers used their depth of knowledge and experience to interpret the data and place it in the context of existing literature, and appropriate journals were identified in order to reach the target audience and deliver maximum impact. Micron also provided a compliance management service to ensure ICMJE and GPP guidelines were adhered to, as well as the SOPs of the client company. Authorship agreements, conflict of interest forms and debarment checks were maintained and recorded on a publications database along with author feedback documents.

Micron worked closely with global publications teams and authors to produce 20 high quality, published manuscripts, including three review articles. Alongside these manuscripts, Micron produced and submitted to major international conferences around 50 abstracts, 98% of which were accepted for poster presentation. In 2014, the team produced a total of 20 posters (two from late-breaker abstracts) for two conferences held 5 weeks apart. Each poster was expertly designed by our in-house graphic designer, printed and delivered to the conference site.